Image may be NSFW.
Clik here to view.
CeQur said today that it acquired a wearable, on-demand insulin delivery system from Johnson & Johnson‘s (NYSE:JNJ) Calibra Medical for an undisclosed amount.
The Calibra device is designed to dose rapid-acting, mealtime insulin for people with Type II diabetes. In a 278-person study, use of the Calibra device resulted in higher ease-of-use and patient satisfaction scores, as well as less glycemic variability compared to insulin injection pens.
Get the full story at our sister site, Drug Delivery Business News.
The post CeQur acquires wearable insulin delivery device appeared first on MassDevice.
